Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial Results of The Company for The Quarter and Half Year Ended on 30th September, 2026 along with Limited Review Report thereon.

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) Tel. 0731-2426700; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2426700 Date: 03rd November, 2026 The Secretary, Corporate Relationship Department The National Stock Exchange of India Limited Bandra Kurla Complex, Mumbai-400051 The Secretary Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers, ‘A’ wing Dalal Street, Mumbai-400001 SUBJECT: Intimation for meeting of Board of the Directors (Serial No. 03/2026-27) of the Company scheduled to be held on Saturday, 14th November, 2026 pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. REFERENCE: Biofil Chemicals and Pharmaceuticals Limited (BSE SCRIP CODE: 524396; NSE SYMBOL: BIOFILCHEM; ISIN: INE829A01014) Dear Sir/Madam, With reference to above captioned subject and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 14th November, 2026, at the Registered Office of the Company to transact the following matters:- 1. To consider and approve the Un-Audited Financial Results of the Company for the Quarter and Half year ended on 30th September, 2026 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair. We are submitting the above said information in XBRL mode (excel template provided by Exchange) along with the submission in PDF mode within prescribed time limit. Further, in continuation to earlier disclosure dated 24th September, 2026, pursuant to Company’s Code of Conduct to regulate, monitor and report trading in Company’s Securities by Insiders framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended,Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Un-Audited Financial Results for the quarter and Half year ended 30th September, 2026 for all designated persons, their immediate relatives and all connected persons covered under the aforesaid code. You are requested to please take on record the above said information for your reference and further needful and disseminate on the website of the Exchange. This is for your information and record. Thanking you, Yours Faithfully FOR BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. No. A71739